The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancerDaniel Hormaechea‐Agulla, Raúl M. Luque, Rafael Sánchez‐Sánchez et al.|The FASEB Journal|2017Cited by 52
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressivenessDaniel Hormaechea‐Agulla, Raúl M. Luque, Manuel D. Gahete et al.|Molecular Cancer|2017Cited by 51
Ghrelin O-acyltransferase (GOAT) enzyme is overexpressed in prostate cancer, and its levels are associated with patient's metabolic status: Potential value as a non-invasive biomarkerDaniel Hormaechea‐Agulla, Raúl M. Luque, Enrique Gómez‐Gómez et al.|Cancer Letters|2016Cited by 38
Oncogenic Role of Secreted Engrailed Homeobox 2 (EN2) in Prostate CancerEnrique Gómez‐Gómez, Raúl M. Luque, Juan M. Jiménez‐Vacas et al.|Journal of Clinical Medicine|2019Cited by 17
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic toolVicente Herrero‐Aguayo, Raúl M. Luque, Prudencio Sáez-Martínez et al.|Molecular Therapy — Nucleic Acids|2022Cited by 11